Literature DB >> 20117460

Hemodialysis hyperhemolysis. A novel mechanism of endothelial dysfunction and cardiovascular risk?

Chenell L Donadee, Mark T Gladwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20117460     DOI： 10.1016/j.jacc.2009.08.061

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.

Authors:  Jan A Graw; Claire Mayeur; Ivy Rosales; Yumin Liu; Venkata S Sabbisetti; Frank E Riley; Osher Rechester; Rajeev Malhotra; H Shaw Warren; Robert B Colvin; Joseph V Bonventre; Donald B Bloch; Warren M Zapol
Journal:  Circulation       Date:  2016-08-11       Impact factor: 29.690

2.  Age of Red Cells for Transfusion and Outcomes in Patients with ARDS.

Authors:  Jan A Graw; Victoria Bünger; Lorenz A Materne; Alexander Krannich; Felix Balzer; Roland C E Francis; Axel Pruß; Claudia D Spies; Wolfgang M Kuebler; Steffen Weber-Carstens; Mario Menk; Oliver Hunsicker
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

3.  Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study.

Authors:  Koichiro Matsumura; Toshika Okumiya; Tetsuro Sugiura; Nobuyuki Takahashi; Yoshihiro Yamamoto; Sanae Kikuchi; Kenichi Fujii; Munemitsu Otagaki; Ichiro Shiojima
Journal:  BMC Nephrol       Date:  2020-09-29       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.